OliX Pharmaceuticals Inc
KOSDAQ:226950
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
KR |
|
SRJ Technologies Group PLC
ASX:SRJ
|
JE |
|
BSA Ltd
ASX:BSA
|
AU |
|
Fraser and Neave Ltd
SGX:F99
|
SG |
|
Emak SpA
MIL:EM
|
IT |
|
E
|
Emak SpA
F:EK4
|
IT |
|
S
|
Signetics Corp
KOSDAQ:033170
|
KR |
Intrinsic Value
Is OliX Pharmaceuticals Inc undervalued or overvalued?
See the intrinsic value estimate for OliX Pharmaceuticals Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
OliX Pharmaceuticals Inc looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with OliX Pharmaceuticals Inc’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What OliX Pharmaceuticals Does
OliX Pharmaceuticals is a drug development company that works on RNA interference, or RNAi, medicines. These are therapies designed to turn down harmful genes that help cause disease. The company mainly builds experimental drugs for conditions such as eye diseases, fibrotic diseases, and other hard-to-treat disorders.
- Headquarters
- Korea KR
- Employees
- 66
- IPO date
- Jul 18, 2018
Revenue & Expenses Breakdown
OliX Pharmaceuticals Inc
Earnings Waterfall
OliX Pharmaceuticals Inc
The intrinsic value for OliX Pharmaceuticals Inc (226950) under the Base Case is hidden KRW.
Compared with the current market price of 105 600 KRW, the stock appears hidden.